The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis

Abstract Background DNA-based non-invasive prenatal testing (NIPT) using maternal blood constitutes an emerging technology for the detection of Down syndrome (DS). The aim of the study was to conduct a cost-effectiveness analysis to evaluate the economic costs and health implications of the introduc...

Full description

Bibliographic Details
Main Authors: J. C. Bayón, E. Orruño, M. I. Portillo, J. Asua
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12962-019-0173-8